Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.72 |
| ▸ | NPC1 | O15118 | 2/20 | 0.72 |
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | TP53 | P04637 | 1/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | MAOA | P21397 | 1/20 | 0.72 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.72 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.72 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.60 |
| ▸ | RELA | Q04206 | 1/20 | 0.60 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2468017 | 1.00 | SMN1; SMN2 (0.72) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| Carbon Monoxide SCHEMBL6905879 | 0.94 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| Carbon Monoxide SCHEMBL6904137 | 0.94 | SMN1; SMN2 (0.66) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| Benzylacetone SCHEMBL28928562 | 0.93 | ALDH1A1 (0.72) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| SCHEMBL11138135 | 0.91 | MAPT (0.62) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| SCHEMBL24799818 | 0.89 | F2RL1 (0.72) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| SCHEMBL1105476 | 0.89 | ALOX5 (0.68) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| SCHEMBL29209947 | 0.87 | SMN1; SMN2 (0.57) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| SCHEMBL22283502 | 0.87 | SMN1; SMN2 (0.57) | SMN1; SMN2NPC1RAB9AKDM4ELMNA | |
| SCHEMBL13498520 | 0.87 | ALOX5 (0.61) | SMN1; SMN2NPC1RAB9AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3873241-B1 | AEROSOLISABLE FORMULATION | NICOVENTURES TRADING LTD (GB) | 2026-05-27 | — | — | EP | claimed |
| US-12600926-B2 | Treatment compositions with modified amino acid dimers for delivering a benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2026-04-14 | — | — | US | claimed |
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-12527344-B2 | Aerosolizable formulation | Nicoventures Trading Limited (GB) | 2026-01-20 | — | — | US | claimed |
| US-20260000592-A1 | TREATMENT COMPOSITIONS WITH ESTERAMINES OR SALTS THEREOF | PROCTER & GAMBLE (US) | 2026-01-01 | — | — | US | claimed |
| US-12509643-B2 | Pro-benefit-agent compounds with carbon/nitrogen bonds | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-30 | — | — | US | claimed |
| US-12478090-B2 | Aerosolizable formulation | Nicoventures Trading Limited (GB) | 2025-11-25 | — | — | US | claimed |
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-12419339-B2 | Aerosolized formulation | Nicoventures Trading Limited (GB) | 2025-09-23 | — | — | US | claimed |
| EP-4353091-B1 | AEROSOLISABLE FORMULATION | NICOVENTURES TRADING LTD (GB) | 2025-08-06 | — | — | EP | claimed |
| EP-1210966-A1 | Gas filter media with donor and/or acceptor function | PAPIERFABRIK SCHOELLER & HOESCH GMBH & CO. KG (DE) | 2002-06-05 | — | — | EP | claimed |
| US-6346402-B1 | ACTS ON OPTICALLY ACTIVE (S)-ALPHA-PHENETHYLAMINE AND PYRUVIC ACID TO FORM ACETOPHENONE AND ALANINE; FOR PRODUCING CHEMICAL INTERMEDIATES OF DRUGS AND AGRICULTURAL CHEMICALS | KANEKA CORPORATION (JP) | 2002-02-12 | — | — | US | claimed |
| US-6153578-A | Fragrance releasing olefinic silanes | GENERAL ELECTRIC COMPANY (US) | 2000-11-28 | — | — | US | claimed |
| EP-1045025-A1 | (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE | KANEKA CORPORATION (JP) | 2000-10-18 | — | — | EP | claimed |
| WO-2000036933-A1 | USE OF N-NEOHEXYL-α-ASPARTYL-L-PHENYLALANINE METHYL ESTER AS A FLAVOR MODIFIER | THE NUTRASWEET COMPANY (US) | 2000-06-29 | — | — | WO | claimed |
| US-6077923-A | CONTAINING GROUPS OF FRAGRANT ESTERS, KETONES, OR ALDEHYDES | GENERAL ELECTRIC COMPANY (US) | 2000-06-20 | — | — | US | claimed |
| US-6075111-A | A POLYSILOXANE HAVING ONE OR MORE SUBSTITUENTS SELECTED FROM A FRAGRANT ALDEHYDE, KETONE OR ESTER | GENERAL ELECTRIC COMPANY (US) | 2000-06-13 | — | — | US | claimed |
| EP-0998911-A2 | Fragrance releasing non-volatile polymeric siloxanes | GENERAL ELECTRIC COMPANY (US) | 2000-05-10 | — | — | EP | claimed |
| EP-0982313-A2 | Fragrance releasing olefinic silanes | GENERAL ELECTRIC COMPANY (US) | 2000-03-01 | — | — | EP | claimed |
| US-5944026-A | FLAVORED CIGARETTE | H.F. & PH.F. REEMTSMA GMBH & CO. (DE) | 1999-08-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509643-B2 | Pro-benefit-agent compounds with carbon/nitrogen bonds | HGFAC, PROKR1, FABP2 | SMN1; SMN2 298/4885NPC1 1646/4885RAB9A 3275/4885 |
| US-20260000592-A1 | TREATMENT COMPOSITIONS WITH ESTERAMINES OR SALTS THEREOF | ARGLU1, DAO, PNISR | SMN1; SMN2 2825/4885NPC1 4025/4885RAB9A 4009/4885 |
| US-12600926-B2 | Treatment compositions with modified amino acid dimers for delivering a benefit agent | F2, C9, S100A8 | SMN1; SMN2 984/4885NPC1 4560/4885RAB9A 4370/4885 |
| US-12527344-B2 | Aerosolizable formulation | CHRND, CHRM4, CHRNA9 | SMN1; SMN2 1867/4885NPC1 551/4885RAB9A 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.